What Was The Outcome Of A 15–20 W Q-Switched Nd:yag Laser Study For Hht? High Long-Term Success Rates For Vascular Lesions

The study demonstrated a high rate of long-term success in treating hereditary haemorrhagic telangiectasia (HHT). In a cohort of 38 patients treated with a 15–20 W Q-switched Nd:YAG laser for nasal and oral lesions, only seven participants experienced a recurrence of symptoms over a three-year period.

Core Takeaway Treating HHT lesions with a 15–20 W Q-switched Nd:YAG laser offers durable remission for the majority of patients. The low recurrence rate over a three-year span indicates this specific power range is highly effective for managing vascular lesions in the nasal and oral cavities.

Analyzing the Study Parameters

To understand the significance of these results, it is necessary to look at the specific constraints and demographics of the study.

Patient Cohort and Target Area

The study focused on 38 participants diagnosed with hereditary haemorrhagic telangiectasia. The treatment specifically targeted lesions located in the nasal and oral areas, which are common sites for problematic bleeding in HHT patients.

Laser Specifications

The intervention utilized a Q-switched Nd:YAG laser. Critically, the power settings were maintained between 15 and 20 W. This high-power approach was the primary variable being evaluated for efficacy.

Recurrence and Long-Term Efficacy

The defining outcome of this study was the stability of the treatment over time.

Low Recurrence Rates

Over the course of a 3-year study period, the majority of patients remained free of recurring symptoms. Only 7 out of the 38 participants experienced a return of telangiectasias.

Nature of Recurrence

For the seven participants who did experience a relapse, the study noted that the recurrence was not uniform. The telangiectasias appeared either at the original site of treatment or in a different location within the treated area.

Understanding the Trade-offs

While the results are positive, it is essential to view them with an objective lens regarding the nature of the condition.

Management vs. Cure

HHT is a genetic condition, meaning laser therapy is a management strategy, not a permanent cure. While 31 patients saw no recurrence, the fact that 7 did serves as a reminder that physiological predispositions remain.

The Possibility of New Lesions

The data indicates that "recurrence" can manifest in different locations. This suggests that while the laser successfully obliterates specific vessels, the underlying pathology may still lead to the formation of new vascular malformations nearby.

Making the Right Choice for Your Goal

When evaluating this treatment protocol for clinical application or personal understanding, consider your specific objectives regarding HHT management.

If your primary focus is long-term symptom relief: The 15–20 W Q-switched Nd:YAG protocol offers a high probability (approx. 81%) of maintaining remission for up to three years.
If your primary focus is minimizing intervention frequency: This high-power approach is preferable, as it significantly reduces the need for repeated sessions compared to lower-efficacy treatments.

Ultimately, this study confirms that adequate power settings are critical for achieving sustained clearance of HHT lesions in the nasal and oral cavities.

Summary Table:

Feature	Study Parameter / Result
Laser Type	Q-switched Nd:YAG Laser
Power Setting	15–20 W
Target Areas	Nasal and Oral Lesions
Success Rate	81% (31 out of 38 patients)
Observation Period	3 Years
Recurrence Rate	18% (7 out of 38 patients)

Elevate Your Clinic's Vascular Treatments with BELIS Professional Laser Systems

Are you looking to provide your patients with industry-leading outcomes for complex vascular conditions like HHT? BELIS specializes in professional-grade medical aesthetic equipment designed exclusively for clinics and premium salons. Our advanced Nd:YAG and Pico laser systems offer the precision and power required for superior lesion management and durable patient results.

Beyond vascular solutions, our comprehensive portfolio includes:

Advanced Laser Systems: Diode Hair Removal, CO2 Fractional, and Microneedle RF.
Body Sculpting: EMSlim, Cryolipolysis, and RF Cavitation.
Specialized Care: Hydrafacial systems, skin testers, and hair growth machines.

Partner with BELIS to bring medical-grade excellence to your practice. Contact us today to receive a customized quote and learn how our technology can enhance your clinical efficiency and patient satisfaction.